ICD-10 Coding for Scleroderma(M34.0, M34.1, M34.81, L94.1)
Complete ICD-10-CM coding and documentation guide for Scleroderma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Scleroderma
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| M34.0 | Progressive systemic sclerosis | Use when there is diffuse skin involvement and rapid organ involvement. |
|
| M34.1 | CR(E)ST syndrome | Use for limited cutaneous disease with CREST features. |
|
| M34.81 | Systemic sclerosis with lung involvement | Use when interstitial lung disease is confirmed in a patient with systemic sclerosis. |
|
| L94.1 | Localized scleroderma (morphea) | Use for localized skin involvement without systemic features. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for diffuse scleroderma
Essential facts and insights about Scleroderma
Primary ICD-10-CM Codes for scleroderma
Decision Criteria
clinical Criteria
- Presence of diffuse skin thickening and organ involvement.
Applicable To
- Diffuse scleroderma
Excludes
- Localized scleroderma (L94.1)
Clinical Validation Requirements
- Skin thickening extending proximal to MCP/MTP joints
- Anti-Scl-70 antibodies
- HRCT showing lung fibrosis
Code-Specific Risks
- Misclassification if skin involvement is not documented properly.
Coding Notes
- Ensure documentation specifies the extent of skin involvement and any organ complications.
M34.1 - CR(E)ST syndrome
Use for limited cutaneous disease with CREST features.
Applicable To
- Limited scleroderma
Excludes
- Diffuse scleroderma (M34.0)
Clinical Validation Requirements
- Presence of CREST features
- Anti-centromere antibodies
Coding Notes
Document specific CREST features and any organ involvement.
M34.81 - Systemic sclerosis with lung involvement
Use when interstitial lung disease is confirmed in a patient with systemic sclerosis.
Applicable To
- Interstitial lung disease in systemic sclerosis
Excludes
- Lung involvement in other conditions
Clinical Validation Requirements
- HRCT showing lung fibrosis
- Reduced FVC and DLCO
Coding Notes
Ensure lung involvement is documented with HRCT and PFT results.
L94.1 - Localized scleroderma (morphea)
Use for localized skin involvement without systemic features.
Applicable To
- Morphea
- Linear scleroderma
Excludes
- Systemic sclerosis (M34 codes)
Clinical Validation Requirements
- Localized skin lesions without systemic involvement
Coding Notes
Document absence of systemic involvement.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Scleroderma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code M34.0.
Impact
Clinical: Leads to misdiagnosis or inappropriate treatment., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials or reduced reimbursement.
Mitigation Strategy
Train clinicians on specific documentation requirements., Use templates to ensure comprehensive notes.
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation Strategy
Confirm absence of visceral involvement; use M34 codes if present.
Impact
Reimbursement: Potential loss of additional reimbursement for complications., Compliance: Failure to meet coding standards., Data Quality: Incomplete clinical picture.
Mitigation Strategy
Require explicit HRCT findings and PFTs in documentation.
Impact
Failure to document all affected organ systems can lead to audit findings.
Mitigation Strategy
Implement comprehensive documentation templates and regular audits.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Scleroderma, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Scleroderma
Use these documentation templates to ensure complete and accurate documentation for Scleroderma. These templates include all required elements for proper coding and billing.
Rheumatology Progress Note
Specialty: RheumatologyRequired Elements
- Skin involvement details
- Organ systems affected
- Lab results
- Treatment responses
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Scleroderma? Ask your questions below.